Research

This week’s Research Roundup highlights cardiovascular concerns in BRCA1 and BRCA2 mutation carriers.

This week’s Research Roundup highlights high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology.

This week’s Research Roundup highlights the blast phase myeloproliferative neoplasm with a Mayo-AGIMM study of 410 patients from two separate cohorts.

A recent article in HealthDay News reported on a case of an avid 26-year-old outdoorswoman from Oregon who became the first human ever infected by a type of eye worm previously seen only in cattle. Audrey Schuetz, M.D., Senior Associate Consultant in the Division of Clinical Microbiology in the Department of Laboratory Medicine and Pathology at Mayo Clinic, comments on the eye worm.

This week’s Research Roundup highlights the genomic analysis using regularized regression in high-grade serous ovarian cancer.

Encephalitis caused by the immune system attacking the brain is similar in frequency to encephalitis from infections, Mayo Clinic researchers report in Annals of Neurology.

This week’s Research Roundup highlights the prediction of oncologic outcomes in Renal cell carcinoma after surgery.

This week’s Research Roundup highlights cryptogenic cirrhosis and sitosterolemia, a treatable disease if identified but fatal if missed.

A new test developed by researchers at Mayo Clinic shows which mutations in the BRCA2 gene make women susceptible to developing breast or ovarian cancers. The research behind the test was published today in the American Journal of Human Genetics.

This week’s Research Roundup highlights pathways impacted by genomic alterations in pulmonary carcinoid tumors.

This week’s Research Roundup highlights improving immune-vascular crosstalk for cancer immunotherapy.

Patients with monoclonal gammopathy of undetermined significance are at risk of progressing to multiple myeloma or a related cancer─even after 30 years of stability, according to findings of a study by Mayo Clinic researchers published in the New England Journal of Medicine.

This week’s Research Roundup highlights how the loss of FOXO1 cooperates with TMPRSS2-ERG overexpression to promote prostate tumorigenesis and cell invasion.